...
首页> 外文期刊>European respiratory review >Subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis
【24h】

Subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis

机译:用于防止呼吸机相关肺炎的秘银分泌引流:系统评价概述和更新的荟萃分析

获取原文
           

摘要

Although several guidelines recommend subglottic secretion drainage as a strategy for prevention of ventilator-associated pneumonia (VAP), its use is not widespread. With the aim to assess the effectiveness of subglottic secretion drainage for preventing VAP and to improve other outcomes such as mortality, duration of mechanical ventilation and length of stay in the intensive care unit (ICU) or hospital, an electronic search of the Cochrane Library, MEDLINE, Web of Science and Embase was undertaken. Nine systematic reviews with meta-analysis (in the overview of reviews) and 20 randomised controlled trials (in the updated meta-analysis) were included. In the overview of reviews, all systematic reviews with meta-analysis included found a positive effect of subglottic secretion drainage in the reduction of incidence of VAP. In the updated meta-analysis, subglottic secretion drainage significantly reduced VAP incidence (risk ratio (RR) 0.56, 95% CI 0.48–0.63; I 2 =0%, p=0.841) and mortality (RR 0.88, 95% CI 0.80–0.97; I 2 =0%, p=0.888). This is the first study that has found a decrease of mortality associated with the use of subglottic secretion drainage. In addition, subglottic secretion drainage is an effective measure to reduce VAP incidence, despite not improving the duration of mechanical ventilation and ICU and/or hospital length of stay.
机译:虽然有几条指南推荐秘收分泌引​​流作为预防呼吸机相关的肺炎(VAP)的策略,但其使用并不普遍。旨在评估防止VAP的脱底分泌引流的有效性,并改善其他结果,如死亡率,机械通风持续时间和重症监护单元(ICU)或医院,电子搜索Cochrane图书馆,采取了Medline,科学和Embase网。九次系统评价Meta-Analysis(在评论中概述)和20项随机对照试验(在更新的META分析中)。在评论的概述中,所有具有Meta分析的系统评论包括在减少VAP的发病率降低时发现脱底分泌引流的积极作用。在更新的荟萃分析中,子凝集分泌引流显着降低了VAP入射(风险比(RR)0.56,95%CI 0.48-0.63; I 2 = 0%,P = 0.841)和死亡率(RR 0.88,95%CI 0.80- 0.97; I 2 = 0%,p = 0.888)。这是第一项研究,发现与使用子凝集分泌引流相关的死亡率降低。此外,秘银分泌引流是减少VAP发病率的有效措施,尽管没有改善机械通气和ICU和/或医院的住宿时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号